American Virtual Cloud (AVCT)

Technical Analysis Historical Data Financials News & Analysis

AVCT NEWS

Avacta Therapeutics Presents Data from Lead pre|CISION® Candidate FAP-Dox (AVA6000) at the 2025 AACR Annual Meeting By AVACTA - 4 days ago

Compelling Phase 1 safety and efficacy data for FAP-Dox (AVA6000) with preliminary evidence of efficacy in salivary gland cancers and no severe cardiac toxicity Progression free survival (PFS) data … [+5414 chars]...

Read more
Top Stock
CurrencyPrice Chg
BA 		185.54 2.65
1.45%
CVX 		136.13 -0.13
-0.09%
CAT 		319.99 6.03
1.92%
INTC 		20.28 0.3
1.49%
MSFT 		437.33 11.93
2.8%
DIS 		92.19 1.38
1.51%
DOW 		30.43 -0.1
-0.33%
CSCO 		58.88 0.76
1.3%
GS 		560.49 6.66
1.2%